glp 1 gip vs tirzepatide Effects of tirzepatide, a dual and GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats Semaglutide vs Tirzepatide: Which GLP-1

Ijms 17 (3), 431

Semaglutide is a single GLP-1 receptor agonist, while tirzepatide acts on both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors

As you gain weight, higher levels of these harmful substances end up in your bloodstream, putting you at risk of serious health conditions such as: High blood pressure High cholesterol Type 2 diabetes Heart disease Osteoarthritis Atherosclerosis Obstructive sleep apnea Fatty liver disease Being overweight also increases your chance of developing breast, endometrial, and colon cancers

Petricoul, O

ORAL SEMAGLUTIDE As an alternative approach, non-peptide, small molecule oral GLP-1 receptor agonists offer a promising option

Researchers have used Retatrutide to evaluate how GIP receptor activation contributes to broader endocrine system interactions